IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $3,390 | +11.5% | 67 | 0.0% | 0.00% | – |
Q3 2023 | $3,039 | +17.6% | 67 | +6.3% | 0.00% | – |
Q2 2023 | $2,585 | +100.9% | 63 | +75.0% | 0.00% | – |
Q1 2023 | $1,287 | +128600.0% | 36 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -100.0% | 36 | -12.2% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 41 | -31.7% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 60 | +25.0% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 48 | +118.2% | 0.00% | – |
Q4 2021 | $1,000 | -50.0% | 22 | -65.6% | 0.00% | – |
Q3 2021 | $2,000 | +100.0% | 64 | +93.9% | 0.00% | – |
Q1 2021 | $1,000 | -100.0% | 33 | -66.0% | 0.00% | -100.0% |
Q4 2016 | $4,640,000 | +105.4% | 97 | 0.0% | 0.00% | – |
Q2 2016 | $2,259,000 | -42.5% | 97 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $3,928,000 | -34.6% | 97 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $6,007,000 | – | 97 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |